Ignite Creation Date:
2024-05-06 @ 1:47 AM
Last Modification Date:
2024-10-26 @ 11:10 AM
Study NCT ID:
NCT01907009
Status:
TERMINATED
Last Update Posted:
2023-04-19
First Post:
2013-07-22
Brief Title:
A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer MEL-CAP
Sponsor:
Barts The London NHS Trust
Organization:
Barts The London NHS Trust
Organization Data
Organization:
Barts The London NHS Trust
Class:
OTHER
Study ID:
PR 2012 06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Barts The London NHS Trust
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None